Stock EDIT EDITAS MEDICINE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Editas Medicine, Inc.

Equities

EDIT

US28106W1036

Market Closed - Nasdaq
Other stock markets
 18:00:00 03/07/2024 BST 		5-day change 1st Jan Change
4.66 USD +2.64% Intraday chart for Editas Medicine, Inc. -1.69% -54.00%
06-27 Editas Medicine, Inc. Announces Resignation of Akshay Vaishnaw from the Board Effective as of June 30, 2024 CI
06-14 Editas Medicine Says Its Gene Editing Potential Treatment for Sickle-Cell Disease Found Well-Tolerated in Phase 1/2 Trial MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
EDITAS MEDICINE, INC. Stock Editas Medicine, Inc.
 383M -
MODERNA, INC. Stock Moderna, Inc.
 44.44B -
LONZA GROUP AG Stock Lonza Group AG
 40.03B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 37.68B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 31.46B -
CELLTRION, INC. Stock Celltrion, Inc.
 27.29B
  1. Stock Market
  2. Equities
  3. EDIT Stock
  4. Charts Editas Medicine, Inc.
  5. Sector Chart